Unique ID issued by UMIN | UMIN000023464 |
---|---|
Receipt number | R000026965 |
Scientific Title | A randomized phaseII study to evaluate quality of life after total gastrectomy using a linear stapler vs a circular stapler for esophagojejunostomy |
Date of disclosure of the study information | 2016/08/03 |
Last modified on | 2024/03/04 11:21:38 |
A randomized phaseII study to evaluate quality of life after total gastrectomy using a linear stapler vs a circular stapler for esophagojejunostomy
Laparoscopic esophagojejunostomy with linear or circular stapler
A randomized phaseII study to evaluate quality of life after total gastrectomy using a linear stapler vs a circular stapler for esophagojejunostomy
Laparoscopic esophagojejunostomy with linear or circular stapler
Japan |
Gastric cancer
Gastrointestinal surgery |
Malignancy
NO
To evaluate the superiority of the linear stapler compared with the circular stapler for esophagojejunostomy after total gastrectomy
Efficacy
Phase II
Postgastrectomy syndrome at 12 months after operation (Complaint will be evaluated by EORTC QLQ-STO22)
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
2
Treatment
Device,equipment | Maneuver |
Esophagojejunostomy is performed using a linear stapler.
Esophagojejunostomy is performed using a circular stapler.
20 | years-old | <= |
Not applicable |
Male and Female
1. Histologically proven adenocarcinoma of the stomach
2. A total gastrectomy with curative intention is planned for gastric cancer located in the upper third of the stomach.
3. cStage I-III
4. No esophageal invasion
5. No gastric stump cancer
6. Sufficient oral intake, and continuous transfusion is not necessary
7. Simultaneous resection of organs other than the gallbladder and spleen is not planned.
8. Over 20 years old
9. Eastern clinical oncology group performance status is 0 or 1.
10. No previous chemotherapy or radiation therapy, including those for other cancers
11. Body mass index is less than 30.
12. Fulfills all of the following conditions
WBC>3,000/mm3
Plt>100,000/mm3
AST<100IU/L
ALT<100IU/L
T.Bil<2.0g.dl
Cre<1.5mg/dl
13. Written informed consent
1. Other active cancer
2. Active infectious disease
3. Possibly pregnant, or breast feeding woman
4. Psychiatric disorder
5. Receiving steroids
6. Acute myocardial infarction within 6 months or unstable angina
7. Uncontrolled hypertension
8. Uncontrolled diabetes mellitus and receiving insulin treatment
9. Pulmonary disease requiring continuous oxygen therapy
50
1st name | Masanori |
Middle name | |
Last name | Terashima |
Shizuoka Cancer Center
Gastric Surgery
411-8777
1007,Shimonagakubo, Nagaizumi, Sunto, Shizuoka
055-989-5222
m.terashima@scchr.jp
1st name | Yusuke |
Middle name | |
Last name | Koseki |
Shizuoka Cancer Center
Gastric Surgery
411-8777
1007,Shimonagakubo, Nagaizumi, Sunto, Shizuoka
055-989-5222
y.koseki@scchr.jp
Shizuoka Cancer Center
Shizuoka Cancer Center
Self funding
Shizuoka Cancer Center
1007,Shimonagakubo, Nagaizumi, Sunto, Shizuoka
055-989-5222
rinsho_office@scchr.jp
NO
2016 | Year | 08 | Month | 03 | Day |
Unpublished
Enrolling by invitation
2015 | Year | 05 | Month | 26 | Day |
2015 | Year | 08 | Month | 25 | Day |
2016 | Year | 08 | Month | 08 | Day |
2027 | Year | 08 | Month | 08 | Day |
2016 | Year | 08 | Month | 03 | Day |
2024 | Year | 03 | Month | 04 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026965